Wolfe Laboratories, Inc. Information

Wolfe Laboratories Inc. is the acknowledged leading provider of early drug development services to the global biopharmaceutical industry. Its client base is comprised of global pharmaceutical and biotechnology companies. Wolfe Laboratories’ expertise and processes are uniquely designed to rapidly characterize a compounds’ pharmaceutical and biopharmaceutical properties and strategically leverage the knowledge gained to de-risk the innovative therapeutics, while working within the time-constrained early development paradigm. Wolfe Laboratories’ services encompass analytical, pre-formulation, formulation, drug metabolism and pharmacokinetics, with streamlined transitions to GLP- and GMP- testing, obviating the need for time-consuming technology transfers and ensuring that programs rapidly advance to nonclinical and clinical evaluation. Wolfe Laboratories’ expert team is experienced in the successful development of parenteral formulations, enabling formulations, biologics, small molecule-macromolecule hybrids, protein-lipid complexes and high potency compounds, all of which are technically demanding and have limited API. Located in the global life science capital outside of Cambridge, Massachusetts, Wolfe Laboratories’ stellar integrated early development team ensures that its clients programs are done correctly and on time. For more information, visit www.wolfelabs.com.